Our data were then compared to all of the publically available human ZEB1‐binding data for human pancreatic carcinoma Panc‐1, human hepatoblastoma HepG2, and the Gm12878 B‐lymphoblastic cell lines using the same read aligner, peak caller, and parameters (Diaferia et al., 2016; Hensen et al., 2014). This evidence concerns the gene ZEB1 and exocrine pancreatic carcinoma.